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Abstract
The theocratical properties of the power of the conventional testing hypotheses and
the selection bias are usually unknown under covariate-adaptive randomized clinical
trials. In the literature, most studies are based on simulations. In this article, we
provide theoretical foundation of the power of the hypothesis testing and the selection
bias under covariate-adaptive randomization based on linear models. We study the
asymptotic relative loss of power of hypothesis testing to compare the treatment effects
and the asymptotic selection bias. Under the covariate-adaptive randomization, (i)
the hypothesis testing usually losses power, the more covariates in testing model are
not incorporated in the randomization procedure, the more the power is lost; (ii) the
hypothesis testing is usually more powerful than the one under complete randomization;
and (iii) comparing to complete randomization, most of the popular covariate-adaptive
randomization procedures in the literature, for example, Pocock and Simon’s marginal
procedure, stratified permuted block design, etc, produce nontrivial selection bias. A
new family of covariate-adaptive randomization procedures are proposed for considering
the power and selection bias simultaneously, under which, the covariate imbalances are
small enough so that the power of testing the treatment effects would be asymptotically
the largest and at the same time, the selection bias is asymptotically the optimal. The
theocratical properties give a full picture how the power of the hypothesis testing, the
selection bias of the randomization procedure, and the randomization method affect
each other.
Keywords:Balancing covariates; Clinical trial; loss of power; Selection bias; Pocock
and Simon’s procedure
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1 Introduction
It is well known that covariates usually play important role in clinical trials. Clinical
trialists often concern about unbalanced treatment arms with respect to key covariates
of interest. To balance important covariates, covariate-adaptive designs (Rosenberger and
Lachin 2002) are usually employed. The most commonly implemented methods are stratified
randomization and marginal minimization (McEntegart 2003). Stratified randomization is
doing stratification first and then employing separate randomization within each strata; for
example, stratified permuted block design, etc. To deal with many covariates, Taves (1974)
and Pocock and Simon (1975) introduced the marginal minimization method, attempting
to minimize the weighted sum of marginal differences between numbers of patients for all
covariates. Hu and Hu (2012) discussed some limitations of these classical designs and
proposed a generalized family of covariate-adaptive designs, and obtained their theoretical
properties. For more discussion of handling covariates in clinical trials, see McEntegart
(2003), Rosenberger and Sverdlov (2008), Zhang et al (2007), Hu and Rosenberger (2006)
and reference therein.
It is important to study the statistical inference associated covariate-adaptive designs. In
practice, conventional tests are often employed without consideration of covariate-adaptive
randomization scheme. It remains a concern if conventional tests are still valid under
covariate-adaptive designs, especially when the covariates used in trial design and those
incorporated in inference procedures are not the same. Simulation studies on the statistical
inference under covariate-adaptive designs are quite a lot, but theoretical work is limited.
Birkett (1985) and Forsythe (1987) raised concerns about validity of unadjusted analysis
under covariate-adaptive designs, and suggested all covariates used in Taves’s minimization
method should be included into analysis to achieve a valid test through simulation stud-
ies. Feinstein and Landis (1976) and Green and Byar (1978) studied inference problems
for stratified randomization for binary responses. Ciolino et. al. (2011) showed that power
loss could be nontrivial if balancing distributions of important continuous covariates were
ignored even if adjustment is made in the analysis for important covariates. More discus-
sions can be found in Simon (1979), Tu, Shalay, and Pater (2000), Aickin (2009), and so on.
Recently, Shao, Yu, and Zhong (2010) and Ma, Hu and Zhang (2015) theoretically proved
that, when some or all covariates used in trial design are not incorporated in inference pro-
cedures, the hypothesis testing to compare treatment effects is usually conservative in terms
of small Type I error. It is now generally accepted that covariates used in trial design should
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also be incorporated in inference procedures.
In this paper, we consider the opposite that covariates incorporated in inference proce-
dures should be use in trial design. We will study the exact power of the hypothesis testing
to compare treatment effects. The expansion of the relative power function is established
and it is showed that when some or all covariates used in inference procedures are not incor-
porated in trial design, the testing usually losses power, the more covariates in the testing
model are not incorporated in the randomization procedure, the more the power is lost, but
the adaptive-randomization is usually more powerful than complete randomization. When
all the covariates incorporated in inference procedures are balanced enough, the power of the
testing is asymptotically equivalent to the largest one. A large class of covariate-adaptive
designs, which includes most of the covariate-adaptive designs in the literature; for example,
Pocock and Simon’s marginal procedure, stratified permuted block design, would achieve
the largest power.
In the literature, continuous covariates are typically discretized in order to be included
in the randomization scheme (Taves 2010, Ma and Hu 2013). However, as discussed in
Scott et. al. (2002), the breakdown of a continuous covariate into subcategories means
increased effort and loss of information. Ciolino et. al. (2011) also pointed out that lack
of publicity for practical methods for continuous covariate balancing and lack of knowledge
on the cost of failing to balance continuous covariates results in a common phenomenon,
whereby continuous covariates are excluded from the randomization plan in clinical trials.
Our theoretical results on the power gives a picture how the discretization affects the loss
of power and give a formula of the cost of failing to balance continuous covariates.
On the other hand, randomization in clinical is fundamental to the design study. Ran-
domization is desirable for a number of reasons including the selection bias which may
arise if the person in charge of selecting patients for the trial has advance knowledge of the
treatment assignments. Efron (1971) discussed how to measure the lack of randomness and
treatment imbalance, and proposed a biased coin design (BCD) to give a tradeoff between
the treatment imbalance and lack of randomness. However, the lack of randomness of the
covariate-adaptive randomization is seldom considered theoretically. Basing on the measure
of selection bias defined by Efron (1971), we will find that, comparing to complete random-
ization, the selection bias of both Pocock and Simon’s marginal procedure and stratified
permuted block design is nontrivial, though the asymptotic power of theses designs would
be the largest. A nature question is whether there is a covariate-adaptive randomization
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procedure under which both the power and the selection bias are optimal. We will propose
a new family of covariate-adaptive designs which include the Pocock and Simon’s marginal
procedure, Hu and Hu (2012)’s design and Wei (1978)’s adaptive biased coin design. Within
this family, a new covariate-adaptive randomization procedure is defined by choosing a suit-
able allocation function, under which the covariate imbalances are small enough so that the
power of testing the treatment effects would be asymptotically the largest and, at the same
time the selection bias attains the minimum value 1/2 so that every guessing strategy is
asymptotically equally useless against the allocation procedure.
In Section 2, we will study the power of the hypotheses testing to compare the treatment
effects. Section 3 will deal with the selection bias. In Section 4, the new family of adaptive-
randomization procedures are proposed. The proofs are given in the last section.
2 The power of hypothesis testing under covariate-adaptive
designs
In this section, we study the power of hypothesis testing based on a linear model frame-
work for covariate-adaptive designs. Suppose two treatments 1 and 2 are studied under a
covariate-adaptive randomized clinical trial, µ1 and µ2 are parameters measuring the main
effects of treatment 1 and 2, respectively. Let n be the total number of patients enrolled in
the study. Let Ti be the assignment of ith patient, i.e., Ti = 1 for treatment 1 and Ti = 0
for treatment 2, i = 1, 2, ..., n. Conditional on the treatment assignment Ti, the following
linear model is assumed for the response of the ith patient Yi,
Yi = µ1Ti + µ2(1− Ti) + β1Xi,1 + ...+ βIXi,I + εi, (2.1)
where
- Xi,ks are discrete or continuous covariates which are independent and identically dis-
tributed as Xk , k = 1, . . . , I;
- partial or all values of Xi,ks are used in the randomization procedure, k = 1, ..., I;
- all covariates are independent of each other, and EXk = 0 and Var(Xk) > 0 for all k,
k = 1, . . . , I;
- εis are independent and identically distributed normal random errors with mean zero
and variance σ2ε and independent of Xk,k = 1, . . . , I.
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Notice Xi,k are assumed to be scalers in model (2.1). If Xi,k is a discrete covariate, Xi,k
is a scaler that can take several values corresponding to different categories. In practice,
a vector is usually used to represent a discrete covariate with multiple categories. In this
paper, Xi,k is assumed to be a scaler for simplicity, but all the results can be extended to
the situation where discrete covariates with multiple categories are represented by vectors.
We let Y = (Y1, Y2, ..., Yn)
T , ε = (ε1, ε2, ..., εn)
T , β = (β1, ..., βI)
T , γ = (µ1, µ2, β1, ..., βI )
T ,
and
X =

T1 1− T1 X1,1 · · · X1,I
T2 1− T2 X2,1 · · · X2,I
...
...
...
. . .
...
Tn 1− Tn Xn,1 · · · Xn,I
 .
Then model (2.1) can be written as
Y =Xγ + ε,
The ordinary least squares method is used to obtain the estimate of γ, which has the explicit
form
γˆ = (XTX)−1XTY = γ + (XTX)−1XTε.
In the covariate-adaptive randomization, the results of allocations T1, . . . , Tn depend only on
the covariates X1, . . . ,Xn, and so are independent of ǫ. Hence, given X, γˆ follows a multi-
dimensional normal distribution with mean γ and variance-covariance matrix σ2ǫ (X
TX)−1.
When model (2.1) is constructed to study data from a covariate-adaptive randomized
clinical trial, the primary interest is usually to compare treatment effects between different
groups. To compare treatment effects of µ1 and µ2, the following right-sided hypothesis
testing is usually used
H0 : µ = 0 versus HA : µ > 0. (2.2)
where µ = µ1 − µ2 is treatment effect difference. The right-sided t-test statistic for (2.2) is
T =
Lβˆ
(σ̂2ǫL(X
TX)−1LT )1/2
, (2.3)
where L = (1,−1, 0, ..., 0), and σˆ2ǫ = (Y −Xβˆ)T (Y −Xβˆ)/(n− I−2) is the estimate of σ2ǫ .
If T > t1−α(ν), where t1−α(ν) is (1− α)th quantile of a t-distribution with degree of freedom
ν = n−I−2, we will reject the null hypothesis, otherwise accept the null hypothesis. Given
X, the conditional power function is
βT,n(µ|X) = 1− F
(
t1−α(ν); ν,
µ
σ2ǫL(X
TX)−1LT )1/2
)
,
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where F (t; ν, δ) is the distribution function of a non-central t-distribution with non-central
parameter δ and degree of freedom ν = n− I − 2.
Let Xi = (Xi,1, · · · ,Xi,I)T ,
Nn,1 =
n∑
i=1
Ti, Nn,2 =
n∑
i=1
(1− Ti), Dn = Nn,1 −Nn,2,
Dxn =
n∑
i=1
(2Ti − 1)Xi, Dxkn =
n∑
i=1
(2Ti − 1)Xi,k, k = 1, . . . , I,
Xn,1 =
∑n
i=1 TiXi
Nn,1
, Xn,2 =
∑n
i=1(1− Ti)Xi
Nn,2
,
Y n,1 =
∑n
i=1 TiYi
Nn,1
, Y n,2 =
∑n
i=1(1− Ti)Yi
Nn,2
,
Sn,xx =
n∑
i=1
Ti(Xi −Xn,1)(Xi −Xn,1)T
+
n∑
i=1
(1− Ti)(Xi −Xn,2)(Xi −Xn,2)T .
Here Dn is the difference between the numbers of patients in treatment group 1 and 2
as total, which can be regarded as a measure of overall treatment imbalance, and, Dxn =∑n
i=1 TiXi −
∑n
i=1(1 − Ti)Xi can be regarded as a measure of covariate imbalance. It can
been seen that
Xn,1 =
nXn +D
x
n
n+Dn
and Xn,2 =
nXn −Dxn
n−Dn
are functions of Dn and D
x
n, where Xn =
∑n
i=1Xi/n. Also
L(XTX)−1LT =
1
Nn,1
+
1
Nn,2
+ (Xn,1 −Xn,2)TS−1xx (Xn,1 −Xn,2)
=
4
n
(
1− (Dn/n)2
) + 4Q2n
n
(
1− (Dn/n)2
)2 ,
where
Q2n =
(
Dxn/
√
n−XnDn/
√
n
)T (Sn,xx
n
)−1 (
Dxn/
√
n−XnDn/
√
n
)
.
Hence, the power function can be written as
βT,n(µ|X) = 1− F
(
t1−α(ν); ν,
µ
2σǫ
ℓn
)
,
where
ℓn =
√√√√ n(1− (Dn/n)2)2
1− (Dn/n)2 + 1nQn
≤ √n.
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Because F (t; ν, δ) is a non-increasing function of δ, it is obvious that when Dn = 0 and
Dxn = 0, the power function takes its largest value
βT,n(µ|0) = 1− F
(
t1−α(ν); ν,
µ
2σǫ
√
n
)
.
A clinical trial is only a single realization of a random phenomenon, and it cannot be assumed
that the observed imbalances Dn and D
x
n will be zero. So, the loss of power is unavoidable.
The problem is, comparing to the largest power, how small is the realized power acceptable?
The distance between the power functions βT,n(µ|X) and βT,n(µ|0) may reflect the loss of
power. However, since the power functions βT,n(µ|X) and βT,n(µ|0) are both convergent to
1, from their difference one can not find how the imbalances Dn and D
x
n effect the loss of
power clearly. To deal with this problem, we consider the relative loss of power as the ratio:
LossPT,n(µ|X) = 1− βT,n(µ|0)
1− βT,n(µ|X) =
F
(
t1−α(ν); ν, u2σǫ
√
n
)
F
(
t1−α(ν); ν, µ2σǫ ℓn
) ,
ν = n− I − 2. The smaller is the value of LossPT,n(µ|X), the more is the power lost.
The following theorem gives the order of the loss of power.
Theorem 2.1 Write σ2x,k = Var(Xk), k = 1, . . . , I,
Vn = (Dn/
√
n)2 +
I∑
k=1
(Dxkn /
√
n)2
σ2x,k
.
Suppose Dnn and
D
x
n
n converge to zero in probability (or almost surely), then
LossPT,n(µ|X) = exp
{
− µ
2
8σ2ǫ
Vn
(
1 + o(1)
)}
. (2.4)
in probability (or almost surely).
In Theorem 2.1, the value of Vn = (Dn/
√
n)2 +
∑p
i=1(D
xk
n /
√
n)2σ−2x,k gives the order of
the loss of power. For the complete randomization in which each patient is allocated to
treatment 1 or 2 with the same probability 1/2,(
Dn√
n
,
Dx1n√
n
, · · · , D
xI
n√
n
)T
d→ NI+1
(
0, diag(1, σ2x,1, · · · , σ2x,I)
)
,
where NI+1 is a (I+1)-dimensional normal distribution with mean and variance-covariance
matrix given between the brackets. So, Vn
d→ χ2(I +1), where χ2(I +1) is a χ2-distributed
random variable with I + 1 degree of freedom. Hence we have
Corollary 2.1 If the patients are allocated to treatments by complete randomization, then
LossPT,n(µ|X) d→ exp
{
− µ
2
8σ2
χ2(I + 1)
}
< 1. (2.5)
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By (2.5), the unconditional relative loss of power is
E [LossPT,n(µ|X)] ∼=
(
1 +
µ2
4σ2ǫ
)− I+1
2
.
The right hand (2.4) will converge to 1 whenever Vn → 0. Therefore, we conclude
Corollary 2.2 If
Dn√
n
→ 0 and D
x
n√
n
→ 0 (2.6)
in probability (or almost surely), then
LossPT,n(µ|X)→ 1
in probability (or almost surely). In such case, the power of the hypothesis testing to compare
treatment effects under this allocation procedure is equivalent to that under the completely
balanced allocation which has the largest power. Such a randomization procedure is called
an efficient covariate-adaptive design.
Condition (2.6) means that the covaritates used in the testing model should be balanced
enough. In clinical trials, covariate-adaptive designs are usually based on discrete covariates
(Taves 2010). If a continuous (or general) covariate is to be used in randomization, a
discrete conversion need be performed to breakdown continuous covariate into a discrete
variable with several subcategories. In general, the covariate-adaptive design is applied
with respect to discrete variables dk(Xk), where dks are discrete functions. In such case,
define δk = Xk − E[Xk|dk(Xk)] and X˜k = dk(Xk). And so, δi,k = Xi,k − E[Xi,k|dk(Xi,k)]
and X˜i,k = dk(Xi,k) are ith observations of covariates δk and X˜k, k = 1, . . . , I. Consider
X˜k have mk levels, resulting in
∏I
k=1mk strata in total. Let X˜i = (X˜i,1, . . . , X˜i,I) represent
the covariate profile of the ith patient used in randomization, i.e., X˜i = (x˜
t1
1 , x˜
t2
2 , . . . , x˜
tI
I )
if X˜i,k is at level x˜
tk
k . For convenience, we use (t1, . . . , tI) to denote the stratum formed
by patients who have the same covariate profile (x˜t11 , . . . , x˜
tI
I ), and use (j; tj) to denote the
margin formed by patients with X˜j = x˜
tj
j . Then let
- Dn = Nn,1 −Nn,2 be the difference between the numbers of patients in treatment group
1 and 2 as total;
- Dn(j; tj) be the differences between the numbers of patients in the two treatment groups
on the margin (j; tj), respectively.
These differences play important roles in properties of statistical inference for covariate-
adaptive designs.
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Theorem 2.2 Let σ2δ,k = E[V ar(δk|dk(Xk))] = E[δ2k], k = 1, . . . , p. Assume that each
assignment Tm depends only on T1, . . . , Tm−1 and X˜1, . . . , X˜m, i.e., the probability of Tm = 1
is a function of T1, . . . , Tm−1 and X˜1, . . . , X˜m. Suppose
Dn√
n
→ 0 and Dn(j; tj)√
n
→ 0 (2.7)
in probability (or almost surely), tj = 1, . . . ,mj , j = 1, . . . , I. Then
LossPT,n(µ|X) d→ exp
{
− µ
2
8σ2ǫ
I∑
k=1
σ2δ,k
σ2x,k
χ2k(1)
}
, (2.8)
where χ21(1), . . . , χ
2
I(1) are independent χ
2-distributed random variables with 1 degree of
freedom. The unconditional relative loss of power is
E [LossPT,n(µ|X)] ∼=
I∏
i=1
(
1 +
µ2
4σ2ǫ
σ2δ,k
σ2x,k
)−1/2
.
Condition (2.7) is satisfied under various covariate-adaptive designs for balancing covari-
ates. For example, under stratified permuted block designs, the class of covariate-adaptive
designs proposed by Hu and Hu (2012), and Pocock and Simon’s marginal procedure,
Dn and Dn(j; tj), are bounded in probability, (2.9)
tj = 1, . . . ,mj , j = 1, . . . , I (c.f. Ma, Hu and Zhang 2015), and so (2.7) is satisfied. Further,
if Xk = dk(Xk), k = 1, . . . , I, then Dn and D
x
n are bounded in probability, resulting in
Vn = O(n
−1) and
LossPT,n(µ|Z) = 1 +O(n−1)
in probability. Note that O(n−1) is the fastest convergence rate unless the treatments are
completely balanced so that Dn = 0 and Dn(j, tj) = 0 for all tj and j, which indicates
that Efron’s biased coin design, as well as its generalizations such as Pocock and Simon’s
marginal procedure and Hu and Hu’s design, is usually efficient in terms of power with
respect to the problem it considered. Similar evidence had also been found in Hu, Zhang
and He (2009) for response-adaptive designs.
In Theorem 2.2, the ratio σ2δ,k/σ
2
x,k describers the cost to loss of power of failing to
balance the kth covariate completely. It is obvious that 0 ≤ σ2δ,k/σ2x,k ≤ 1. The larger
σ2δ,k is, the larger the cost is. If E[Xk|dk(Xk)] = Xk, i.e., the k-covariate is not considered
in the randomization, then σ2δ,k/σ
2
ǫ,k = 1 and accordingly, the k-covariate contributes its
all to the loss of power and so the cost is the largest. If E[Xk|dk(Xk)] = dk(Xk), i.e.,
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the kth covariate is discrete and is balanced enough with respect to all of its values, then
σ2δ,k = 0 and accordingly, the contribution of the k-covariate to the loss of power can be
neglected. So, the less of the covariates and their values are balanced, the more the power is
lost. Comparing the results in Corollary 2.1 and Theorem 2.2, we find that the hypothesis
testing to compare treatment effects under a covariate-adaptive randomization procedure is
usually more powerful than the one under complete randomization.
In the literature, covariate-adaptive randomization schemes are usually based on dis-
crete covariates. When the covariates are continuous, the covariates are usually discretized.
However, as discussed in Scott et. al. (2002), the discretization means increased effort and
loss of information. Ciolino et. al. (2011) also pointed out that uncontrolled imbalances in
continuous covariates may affect the statistical analysis of the trial outcome. In the formula
(2.8), σ2δ,k is the variances of the uncontrolled part of the kth covariate. It is impossible to
be zero when the kth covariate is continuous, and the ratio σ2δ,k/σ
2
x,k just gives the cost of
failing to balance the continuous covariate Xk completely. It is easily seen that the cost can
be decreased by refining the discretization.
The inconsistency of the covariates considered in the randomization and the covariates
used in the hypothesis testing for treatment effects may affect the hypothesis testing. The
evidences have been found in many simulation studies (c.f, Birkett 1985, Forsythe 1987, Tu,
Shalay, and Pater 2000, Aickin 2009, Ciolino et al 2011 etc.). Ma, Hu and Zhang (2015)
derived the theory for the case that the covariates considered in the testing are less than those
considered in the randomization under a large class of covariate-adaptive randomization
procedures satisfying (2.9) (c.f, their conditions (A) and (B)). Here we consider the converse
case. Following the lines of Ma, Hu and Zhang’s proofs, one can find that their Theorems 3.1
and 3.2 remains true when (2.9) is replaced by (2.7). Combing the results in Theorem 2.2
and those of Ma, Hu and Zhang (2015), we conclude that, under a large class of covariate-
adaptive designs for balancing covariates, (i) if the covariates considered in the testing
are less than those considered in the randomization, then the hypothesis testing is usually
conservative in terms of small Type I error, and, the more of the values of covariates are
not consistent, the more the testing is conservative; (ii) if the covariates considered in the
testing are more than those considered in the randomization, then the hypothesis testing
usually losses power, and, the more of the values of covariates are not consistent, the more
the power is lost; (iii) in any case, the hypothesis testing is usually more powerful than the
one under complete randomization.
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Remark 2.1 The conclusions of Theorems 2.1 and 2.2 remain true when the statistic |T |
is used to test the following two-sided hypothesis testing
H0 : µ = 0 versus HA : µ 6= 0. (2.10)
When σ2ǫ is known. Theorems 2.1 and 2.2 are also valid for one-sided or two-sided z-test.
The formula (2.4) reamains true under the alternative hypothesis with 0 < µ = µn → 0
and µn
√
n→∞. But it no longer holds when a sequence of local alternative hypotheses of
the type HA : µ = η/
√
n > 0 are considered. In such case, one can show that ddδF (t; ν, δ)
converges to a continuous function f∞(t; δ) < 0 as ν →∞ uniformly in t and δ on bounded
intervals. It follows that
F
(
t1−α(ν); ν,
η
2σǫ
µn√
n
)
− F
(
t1−α(ν); ν,
η
2σǫ
)
=− η
4σǫ
f∞
(
z1−α;
η
2σǫ
)n− µ2n
n
(
1 + o(1)
)
= Cα,η
Vn
n
(
1 + o(1)
)
.
Hence
βT,n(u|0)− βT,n(u|X) = O(1)Vn
n
. (2.11)
The value of Vn also reflects the order of losing power. When the distribution of model error
ǫi is not normal, though it is difficult to derive the exact power function, (2.11) is expected
to be true especially when the errors follows a continuous distribution. An approximation
method is usually applied to approximate the true distribution of the statistic T for hypoth-
esis testing, when the distribution of error ǫi is not normal or unknown. It is well known
that if normal approximation is used, the approximation precision of the distribution as
well as the power function is O (1/
√
n). If the Bootstrap method is used, the approximation
precision would be improved to O (1/n). Hence, comparing to the approximation precise,
the loss of power O(1)Vnn can be ignored whenever Vn → 0. Again, the condition (2.6) is
needed.
3 Selection bias
As advocated in Efron (1971), selection bias (lack of randomness) of the design shows in
the possibility for the experimenter to guess partially the sequence of treatment allocations;
thus it can be measured, say, by the expected percentage of correct guesses when an optimal
11
guessing strategy is used. Let Jm = 1 if themth assignment is guessed correctly, and Jm = 0
otherwise. The expected proportion of correct guesses is
SBn(∆) = E
[
1
n
n∑
m=1
Jm
]
=
1
n
n∑
m=1
P(Jm = 1)
Here ’∆’ stands for selection bias of the allocation procedure ∆. Every guessing strategy is
equally useless against complete randomization, yielding the expected percentage of correct
guesses 12 for any n; this is then the optimal value of SBn. Clearly 1/2 ≤ SBn(∆) ≤ 1 for
any allocation procedure design ∆. An equivalent way is to consider Smith’s (1984) index,
namely the difference between the mean percentage of correct guesses and that of incorrect
guesses: Un(∆) = 2SBn(∆)− 1, which has the advantage of going from 0 to 1.
For all the adaptive randomization, the optimal strategy consists, at each step, of picking
the under-represented treatment, which is always the treatment with the higher probability
of being allocated, with no preference in case of a tie. Let pm be the conditional probability of
assigning the m-patient to treatment 1 given the history σ-field including the information of
historical allocations, historical covariates and current covariate observed. The probability
that the mth assignment is guessed correctly is E[pm ∨ (1− pm)]. So,
SBn(∆) =
1
n
n∑
m=1
E [pm ∨ (1− pm)] = 1
2
+
1
n
n∑
m=1
E
[∣∣pm − 1
2
∣∣].
It is easily seen that SBn(∆) > 1/2 unless pm ≡ 1/2 for m, i.e., the procedure is com-
plete randomization. In general, we consider the asymptotic selection bias SB(∆) =
limn→∞ SBn(∆).
Under stratified permuted block designs, or Taves (1974)’s minimization method, a posi-
tive percentage of patents are assigned deterministically, and so is guessed correctly, resulting
in
lim inf
n→∞ SBn > 1/2.
For the class of biased coin designs, when the design does not include the covariate, Efron
(1971) gives the formula of the asymptotic selection bias SB of his original biased coin
design which indicates that SB(BCD) > 1/2.
For the Pocock and Simon (1975)’s procedure, no close form of the asymptotic selection
bias SB has been found in literature. Pocock and Simon’s procedure is a generalization
of biased coin design for balancing covariates. Under this procedure, after m − 1 (m > 1)
assignments and suppose the covariate value of the mth patient is observed and falls within
stratum (t1, . . . , tI), themth patient is then randomized by tossing a biased coin according to
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the value of weighted sum of marginal imbalances Λm−1(t1, . . . , tI) =
∑I
j=1wjDm−1(j, tj).
When this value is negative, the probability pm of assigning the patient to treatment 1 is
p (1/2 < p < 1), when it is positive, the probability is q (= 1 − p), and when it is zero,
the probability is 1/2. Due to Theorem 3.3 of Ma, Hu and Zhang (2015) and its proof,
{Λn(t); tj = 1, · · · ,mj , j = 1, · · · , I} is an irreducible positive recurrent multi-dimensional
Markov Chain with an invariant distribution π, where t = (t1, . . . , tI), and so
SB(PC)− 1
2
= lim
n→∞
1
n
n∑
m=1
E[|pm − 1
2
|]
=
(
p− 1
2
)
lim
n→∞
1
n
n∑
m=1
∑
t
P (Λm−1(t) 6= 0) p(t)
=
(
p− 1
2
)∑
t
π (Λ(t) 6= 0) p(t) > 0,
by the ergodic theorem, where p(t) = P(X˜ = (x˜t11 , ..., x˜
tI
I )) > 0. Here the last inequality is
due to the fact that the Markov chain is irreducible and so each possible state has a positive
probability mass under the invariant distribution. For the Hu and Hu’s (2012) procedure, the
stratified biased coin design, we have a similar result. In general, Pocock and Simon (1975)’s
procedure can be generalized by defining the allocation probability pm = g(Λm−1(t)) as a
non-increasing function of the weighted imbalances Λm−1(t) with 0 < g(x) < 1, g(0) = 1/2
and g(x) 6≡ 1/2 (c.f. Antognini and Giovagnoli 2004). With a similar argument, we also
have
SB(GPC)− 1
2
=
∑
t
Epi
[∣∣∣∣g(Λ(t)) − 12
∣∣∣∣] p(t) > 0.
So, for all the covariate-adaptive randomization that have been introduced so far, when
the condition (2.7) is satisfied so that the loss of power would be neglectable, the asymptotic
selection bias SB is larger than 1/2 so that the lack of randomness is nontrivial .
When the clinical trials have many covariates, one may think that it is hard for the
experimenter to know all the information so that he/or she can use an optimal guessing
strategy, and so the selection bias can be ignored. We can show that this is not the true
at least for the Pocock and Simon (1975)’s procedure. Write the allocation probability
pm = g(Λm−1(X˜m)) as a function of Λm−1(X˜m). The guessing strategy is to guess treatment
1 when Gm > 0, treatment 2 when Gm < 0, and guess treatment 1 or 2 with probability 1/2
when Gm = 0, where Gm is the guessing factor. Then the expected proportion of correct
guesses is
SBn(g,G) =
1
2
+
1
n
n∑
m=1
E
[(
pm − 1
2
)
sgn(Gm)
]
,
13
where ”g” stands for the allocation g(x), ”G” stands for the guessing strategy Gm. Because
the experimenter uses part or all information of Λm−1(X˜m), so Gm = G(Λm−1(X˜m)) is
a function of Λm−1(X˜m), where G(·) is a random function. We assume that under the
guessing strategy, the allocation is guessed in a correct direction, i.e., for any point x, y,
P
({G(x)−G(y)} · {g(x)− g(y)} ≥ 0) = P (x, y) ≥ 1/2, and there is at least a pair of points
x0 and y0 such that P
(
G(x0) > 0 > G(y0), g(x0) > g(y0)
)
> 1/2.
Theorem 3.1 For the Pocock and Simon’s procedure, Hu and Hu’s procedure or more gen-
eral procedures as in Remark 4.1, we have
lim
n→∞SBn(g,G) >
1
2
.
Proof. Let Λ∗n−1(t), X˜
∗
n be independent copies of Λn−1(t), X˜n and define p∗m and G∗m
similarly. Write ηm = Λn−1(X˜n), η∗m = Λ∗n−1(X˜
∗
n), η = Λ(X˜), η
∗ = Λ∗(X˜∗). Then
SBn(g,G) − 1
2
=
1
n
n∑
m=1
E
[
pm − 1
2
]
E [sgn(Gm)]
+
1
2
1
n
n∑
m=1
E
[(
pm − p∗m
)(
sgn(Gm)− sgn(G∗m)
)]
=
1
n
n∑
m=1
E
[
pm − 1
2
]
E [sgn(Gm)]
+
1
2
1
n
n∑
m=1
E
[∣∣∣(pm − p∗m)(sgn(Gm)− sgn(G∗m))∣∣∣ (2P (ηm, η∗m)− 1)]
→Eπ
[
g
(
η)
) − 1
2
]
E [sgn[G(η)]] +
1
2
Eπ
[∣∣∣(g(η) − g(η∗))(sgn(G(η)) − sgn(G(η∗)))∣∣∣ (2P (η, η∗)− 1)] ,
by the ergodic theorem. For the limit value, the second term is positive due to the assump-
tion for guessing in a correct direction. The first term is zero because Eπg(η) = 1/2 under
the invariant distribution π, which can be verified by
Eπ[Dn]
n
=
1
n
n∑
j=1
Eπ[2Tj − 1] = 1
n
n∑
j=1
2(Eπpj − 1) = 2Eπg(η) − 1.
The proof is completed. 
It is obvious that, if
pm → 1
2
in probability, (3.1)
then SB attains the minimum value 1/2 of the selections biases, and every guessing strategy
is asymptotically equally useless against the design. When the trials do not include the
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covariate, Wei (1978) defines the adaptive BCD satisfying (3.1) such that SB = 1/2. But
Wei’s design does not satisfy (2.7). The problem is that, can we find a randomization
procedure such that SB = 1/2 and the condition (2.7) is also satisfied? The next section
will deal with this problem.
4 New family of Covariate-Adaptive Randomization meth-
ods
In this section, we consider the randomization methods. We first give a general frame-
work of the covariate-adaptive randomization. We consider the same setting as that of
Pocock and Simon (1975) and only focus on two treatment groups 1 and 2 here. As be-
fore, let Tj be the assignment of the jth patient, j = 1, . . . , n, i.e., Tj = 1 for treatment
1 and Tj = 0 for treatment 2. Recall that X˜j =
(
d1(Xj,1, . . . , dI(Xj,I)
)
indicates the dis-
crete part of the covariate profile of that patient considered in adaptive randomization, i.e.,
X˜j = (x˜
t1
1 , . . . , x˜
tI
I )) if his or her ith covariate is at level x˜
ti
i , 1 ≤ i ≤ I and 1 ≤ ti ≤ mi.
For convenience, we use (t1, . . . , tI) to denote the stratum formed by patients who possess
the same covariate profile (x˜t11 , ..., x˜
tI
I ), resulting in M =
∏I
i=1mi strata, and use (i; ti) to
denote the margin formed by patients whose ith covariate is at level x˜tii .
4.1 The randomization procedure
The procedure is defined as follows:
1) The first patient is assigned to treatment 1 with probability 1/2.
2) Suppose (n − 1) patients have been assigned to treatments (n > 1) and the covariate
value Xn = x
∗
n of the nth patient is observed and falls within stratum (t
∗
1, . . . , t
∗
I).
3) For the first (n− 1) patients,
- let Dn−1 = Nn−1,1−Nn−1,2 be the difference between the numbers of patients in
treatment group 1 and 2;
- similarly, let Dn−1(i; t∗i ) and Dn−1(t
∗
1, . . . , t
∗
I) be the differences between the num-
bers of patients in the two treatment groups on the margin (i; t∗i ), and within the
stratum (t∗1, . . . , t
∗
I), respectively;
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- each one of these differences is used to measure the imbalance at the corresponding
level (overall, marginal, or within-stratum).
4) If the nth patient were assigned to treatment 1, then D
(1)
n = Dn−1 + 1 would be the
“potential” overall difference in the two groups; similarly,
D(1)n (i; t
∗
i ) = Dn−1(i; t
∗
i ) + 1
and
D(1)n (t
∗
1, . . . , t
∗
I) = Dn−1(t
∗
1, . . . , t
∗
I) + 1
would be the potential differences on margin (i; t∗i ) and within stratum (t
∗
1, . . . , t
∗
I),
respectively.
5) Define an imbalance measure Imb
(1)
n by
Imb(1)n = wo[D
(1)
n ]
2 +
I∑
i=1
wm,i[D
(1)
n (i; t
∗
i )]
2 + ws[D
(1)
n (t
∗
1, . . . , t
∗
I)]
2,
which is the weighted imbalance that would be caused if the nth patient were assigned
to treatment 1. wo, wm,i (i = 1, . . . , I) and ws are nonnegative weights placed on
overall, within a covariate margin and within a stratum cell, respectively. Without
loss of generality we can assume
wo + ws +
I∑
i=1
wm,i = 1.
6) In the same manner we can define Imb
(2)
n , the weighted imbalance that would be
caused if the nth patient were assigned to treatment 2. In this case, the three types
of potential differences are the existing ones minus 1, instead of plus 1.
7) Conditional on the assignments of the first (n − 1) patients as well as the covariates’
profiles of the first n patients, assign the nth patient to treatment 1 with probability
P (Tn = 1|Zn−1, X˜n = (x˜t
∗
1
1 , . . . , x˜
t∗I
I ),Tn−1)
= gn
(
Imb(1)n − Imb(2)n
)
(4.1)
where n > 1, Zn−1 = (X˜1, . . . , X˜n−1), Tn−1 = (T1, . . . , Tn−1). Here gn(x) is a real
function with 0 ≤ gn(x) ≤ 1. It is called an allocation function.
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Using the basic equation (x+ 1)2 − (x− 1)2 = 4x, the critical quantity Imb(1)n − Imb(2)n
in Step 7) can be simplified as
Imb(1)n − Imb(2)n
=4
{
woDn−1 +
I∑
i=1
wm,iDn−1(i; t∗i ) +wsDn−1(t
∗
1, . . . , t
∗
I)
}
:=4 · Λn−1(t∗1, . . . , t∗I) (4.2)
Therefore, the allocation probability gn
(
Imb
(1)
n − Imb(2)n
)
is determined by the value of
Λn−1(t∗1, . . . , t
∗
I), which is a weighted average of current imbalances at different levels.
This framework includes various kinds of covariate-adaptive randomization procedures.
If stratified randomization is considered, one just need to let ws = 1 and other weights to
be zero. If wo = ws = 0, the design is a marginal randomization procedure. Hu and Hu
(2012)’s design is a special case with the weights satisfying some specified conditions.
4.2 The choice of the allocation function
In the literature different views have been given as to the selection of the allocation proba-
bility function gn(·). Efron (1971), Pocock and Simon (1975), Hu and Hu (2012) suggested
gn(x) =

q, if x > 0,
1
2 , if x = 0,
p, if x < 0,
(4.3)
where p > 1/2 and q + p = 1. If the allocation function is chosen in this way, and ws =
wo = 0, then the design is the Pocock and Simon (1975)’s marginal procedure. Ma, Hu
and Zhang (2015) had theoretically proved that under Pocock and Simon’s procedure, the
marginal imbalances and overall imbalance are bounded in probability. But the selection
bias is not optimal as we have seen in Section 3.
When the design does not include the covariate, Wei (1978) defines the adaptive BCD
with allocation function being defined as
gn(x) = g
(
x
n− 1
)
, (4.4)
where g(x) is a non-increasing function with 0 ≤ g(x) ≤ 1, g(x) = 1 − g(−x), g(0) = 0.5
and g′(0) < 0. It has been showed that SB(WeiBCD) = 1/2, which attains the minimum
value as complete randomization does. However, Wei’s BCD does note satisfy the condition
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(2.7) and so power loss could be nontrivial (c.f. Antognini and Giovagnoli 2004, Antognini
2008).
Next, we show that a covariate-adaptive design can be defined by choosing suitable
allocation function gn(x) so that the selection bias is asymptotically the minimum and the
covariate imbalances considered are of the order of o(n1/2) in probability for which the loss
of power would be negelectable.
In general, we assume the allocation function gn(x) (0 ≤ gn(x) ≤ 1) satisfying the
following conditions
gn(x) ≤ 1/2 ≤ gn(−x) when x ≥ 0, (4.5)
|1/2 − gn(xn)|
|xn|/n → +∞ whenever 0 <
|xn|
n
→ 0 (4.6)
and
gn(xn)→ 1
2
whenever
xn
n
→ 0. (4.7)
We will show that if the allocation function satisfy the conditions (4.5) and (4.6), then
covariate imbalances are of the order of o(n1/2) in probability and, if the conditions (4.5)
and (4.7) are satisfied, then the asymptotically selection bias is 1/2. The allocation function
gn(x) of BCD given in (4.3) satisfies (4.5) and (4.6), but it does not satisfy condition (4.7).
Wei’s allocation function gn(x) given in (4.4) satisfies (4.5) and (4.7) , but it does not satisfy
condition (4.6).
It is easily seen that gn(x) = 1−Φ
(
sgn(x)
√
|x|/n
)
satisfy all the condition (4.5)-(4.7),
where Φ(x) is the standard normal distribution function. It can be chosen as an allocation
function to define a design as desired.
In the following we will give a specified allocation function. For this allocation function,
the design has much fine properties. Let 0 ≤ g(x) ≤ 1 be a non-increasing function with
g(0) = 0.5, g′(0) < 0. Define
gn(x) = g
(
x
(n− 1)γ
)
, 0 ≤ γ ≤ 1. (4.8)
When γ = 1, the allocation function gn(x) is Wei’s function given in (4.4). When γ = 0, the
design is a generalization of the Pocock and Simon (1975)’s procedure as well as Hu and Hu
(2012)’s design. In this paper, we mainly consider the case 0 < γ < 1. When 0 ≤ γ < 1, the
allocation function given in (4.8) satisfied the condition (4.5) and (4.6), but may not satisfy
(4.7). However, we will show that the design defined by this allocation function satisfy (3.1)
when 0 < γ ≤ 1.
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4.3 Theoretical Properties
For consider the asymptotic properties of the design, we need some more notations. For the
first n patients, we know that Dn(t1, . . . , tI) is the true difference between the two treatment
arms within stratum (t1, . . . , tI). Let
Dn = [Dn(t1, . . . , tI)]1≤t1≤m1,...,1≤tI≤mI
be an array of dimension m1 × . . . × mI which stores the current assignment differences
in all strata and so stores the current imbalances. Also, the covariates X˜1, X˜2, . . . are in-
dependently and identically distributed. Since X˜n = (x˜
t1
1 , ..., x˜
tI
I ) can take M =
∏I
i=1mi
different values, it in fact follows an M -dimension multinomial distribution with parameter
p = (p(t1, . . . , tI)), each element being the probability that a patient falls within the corre-
sponding stratum. Without loss of generality, we assume p(t1, . . . , tI) > 0 for all (t1, . . . , tI).
Write t = (t1, . . . , tI). Define
Mn =
∑
t
wsD
2
n(t) +
I∑
i=1
mi∑
ti=1
wm,iD
2
n(i; ti) +woD
2
n.
Now we give our main results.
Theorem 4.1 Suppose the allocation function gn(x) satisfying the conditions (4.5) and
(4.6). Then
E
(
Mn
n
)r
→ 0 ∀r > 0, (4.9)
i.e., Mn = o(n) in Lr for all r > 0. In particular,
(i) If ws > 0, then Dn = o(n
1/2) in Lr for any r > 0;
(ii) If ws + wm,i > 0, then Dn(i; ti) = o(n
1/2) in Lr for any r > 0, ti = 1, . . . ,mi;
(iii) For any case Dn = o(n
1/2) in Lr for any r > 0.
Further, if the condition (4.7) is satisfied, then
SBn → 1
2
.
Theorem 4.2 Let the allocation function gn(x) be defined as (4.8) with 0 < γ ≤ 1, and
0 ≤ g(x) ≤ 1 be a non-increasing function with g(0) = 1/2, g′(0) < 0. Then
Mn = O(n
γ) in Lr for all r > 0, (4.10)
Mn = o(n
γ+ǫ) a.s. for any ǫ > 0 (4.11)
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and
SBn =
1
2
+O(n−γ/2). (4.12)
In particular,
(i) If ws > 0, then Dn = O(n
γ/2) in Lr for any r > 0, and Dn = o(n
γ/2+ǫ) a.s. for any
ǫ > 0;
(ii) If ws+wm,i > 0, then Dn(i; ti) = O(n
γ/2) in Lr for any r > 0, and Dn(i; ti) = o(n
γ/2+ǫ)
a.s. for any ǫ > 0, ti = 1, . . . ,mi;
(iii) For any case Dn = O(n
γ/2) in Lr for any r > 0, and Dn = o(n
γ/2+ǫ) a.s. for any
ǫ > 0;
(iv) Suppose ws+wm,i > 0, Xi = di(Xi) (the covariates in the test and in the randomization
procedure are the same), i = 1, . . . , I. Then
LoPT,n(µ|X) = 1 +O
(
nγ−1
)
in probability.
Further, in (4.12), O(n−γ/2) can be written as ann−γ/2 with
c0 < lim inf
n→∞ an ≤ lim supn→∞ an ≤
2
√
|g′(0)|
2− γ ,
where c0 > 0 is a constant which does not depend on γ.
The value of γ gives the order of the allocation bias as well as the order of selection bias,
which gives a picture how the efficiency and selection bias conflict each other. The smaller
γ is, the smaller the allocation bias is, but the larger the selection bias is. In practice, one
may choose γ = 1/2 to give a tradeoff between two kinds of bias, both of which are medium.
Remark 4.1 Theorem 4.2 does not conclude the case of γ = 0. When γ = 0, suppose
0 < g(x) ≤ 1/2 ≤ g(−x) < 1 for all x ≥ 0, and lim inf
x→∞ |g(x) − 1/2| > 0. It can be showed
that [Λn(t1, . . . , tI)]ti=1,...,mi,i=1,...,I is a positive recurrent Markov chain with an invariant
distribution π and supn E [M
r
n] <∞ for all r > 0. Further,
lim
n→∞SBn =
1
2
+
∑
t
Epi
[∣∣∣g(Λ(t)) − 1
2
∣∣∣]p(t) > 1/2.
So, Theorem 4.2 is still valid for γ = 0. For details, one can refer to Hu and Zhang (2013).
20
5 Concluding Remarks
In this paper, we studied the theoretical properties of hypothesis testing, selection bias
and randomization methods under covariate-adaptive designs. Basing on a linear normal
model framework, we derived the corresponding asymptotic power of the hypothesis testing
to compare treatment effects. To applying Theorem 2.2 to a specific covariate-adaptive ran-
domized clinical trial and find efficient randomization, one just need to check the condition
(2.7) or (2.6). The conclusion can be applied to a broad range of designs, including stratified
permuted block design and Pocock and Simon’s procedure. The asymptotic selection bias is
also studied. To check or find a most random covariate-adaptive randomization procedure,
one just need to check a simple condition (3.1). A new family of covariate-adaptive ran-
domization procedures are showed to satisfy the condition (2.7) and (3.1) simultaneously.
The results in this paper provide new insights about balance, selection bias, efficiency, ran-
domization method of clinical trials, and the framework can be used to study properties
of other statistical methods under covariate-adaptive randomization procedures and define
new covariate-adaptive randomization procedures.
The condition (2.6) is important for ensuring that the asymptotic loss of power can be
ignored so that the randomization procedure is efficient. When the covariates are discrete,
it is satisfied for a large family of covariate-adaptive designs, including many popular de-
signs in literature, and the new family proposed in this paper. But, all covariate-adaptive
designs considered in this article are based on discrete covariates. When the covariates are
continuous, covariates are typically discretized in order to be included in the randomization
scheme. Formula (2.8) gives the cost to the loss of power of failing to balance the kth co-
variate completely when a randomization scheme is included by breakdowning continuous
covariate into a discrete variable with several subcategories. One may consider covariate-
adaptive designs (Lin and Su 2012; Ma and Hu 2013) that directly use continuous covariates
without discretization. However, related theoretical work is limited in the literature. The
loss of power is seldom considered. We leave this as a future research project. There are
some other kinds of covariate-adaptive randomization procedures in the literature, including
Zelen (1974), Begg and Iglewicz (1980), and Atkinson (1982). Theorems 2.1 and 2.2 may not
apply to these designs, because it is unknown whether the condition (2.6) or (2.7) remains
true for these designs.
The proposed properties for covariate-adaptive designs can be generalized in several
ways. First, the proposed properties and adaptive-randomization procedures are based on
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clinical trials with two treatments, which can be generalized to multiple treatments (Hu and
Zhang 2004, Tymofyeyev, Rosenberger, and Hu 2007). Second, one assumption to derive
theoretical results on the power is the independence between covariates. We may apply the
similar idea to dependent covariates by incorporating correlation structure. Third, to derive
the relative loss of power, one important assumption is the normality of the regression
errors. It is an open problem whether the conclusions in Theorems 2.1 and 2.1 are still
valid for a general distribution of errors, especially when an approximation distribution
is applied. Maybe, this is a difficult problem and, the precise self-normalized Crame´r-
type large deviation is helpful for solving it (c.f. Jing, Shao and Wang 2003). Fourth,
the randomization procedures considered in this paper only depend on the covariates, the
response of patients to treatments are not incorporated. It is possible to generalize the
results to efficient randomized response-adaptive designs (Hu, Zhang and He 2009) and
covariate-adjusted adaptive designs (Zhang et al 2007). Those topics are left for future
research.
6 Appendix: Proofs
We first prove the results on the power of the hypothesis testing to compare treatment
effects.
6.1 Proofs of the results in Section 2
Proof of Theorem 2.1. Write Wn = (Dn/
√
n)2 +Q2n. Then
n− ℓ2n =Wn +O(1)
W 4n
n
=Wn
(
1 + o(1)
)
.
Let H(x) = lnF (t1−α(ν); ν,
√
x). Then
H ′(x) =
1
2
d
dδF (t1−α(ν); ν, δ)
δF (t1−α(ν); ν, δ)
∣∣∣∣∣
δ=
√
x
.
We first show that
d
dδF (t; ν, δ)
δF (t; ν, δ)
→ −1 as δ →∞ and ν →∞ (6.1)
uniformly in t on a bounded interval. Note
F (t; ν, δ) = E
[
Φ
(
t
√
χ2(v)/v − δ)] ,
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ddδ
F (t; ν, δ) = −E
[
ϕ
(
t
√
χ2(v)/v − δ)] ,
where χ2(ν) is a random variable which has a χ2 distribution with degree of freedom ν.
Choose a sequence ǫν such that 0 < ǫν → 0, ǫνδ2 →∞ and ǫνν →∞. Let E = {χ2(v)/v ≤
ǫνδ
2}. Note
ϕ(δ)
δ
1 + δ2
≤ 1−Φ(δ) ≤ ϕ(δ)1
δ
.
On the event E,
ϕ
(
t
√
χ2(v)/v − δ)
δΦ
(
t
√
χ2(v)/v − δ) → 1
uniformly in t on a bounded interval and ω. Hence
E
[
ϕ
(
t
√
χ2(v)/v − δ)IE] = (1 + o(1))δE [Φ(t√χ2(v)/v − δ)IE]
uniformly in t on a bounded interval. On the other hand,
P(Ec) ≤e−νǫνδ2/4E
[
eχ
2(v)/4
]
≤ e−ν(ǫνδ2/4−1) ≤ e−2δ2
≤e−δ2δΦ(−δ) ≤ e−δ2δF (t; ν, δ)
when δ and ν large enough. Hence
E
[
ϕ
(
t
√
χ2(v)/v − δ)] = (1 + o(1))δE [Φ(t√χ2(v)/v − δ)]
uniformly in t on a bounded interval. (6.1) is proved, which implies
H ′(x) =
1
2
d
dδF (t1−α(ν); ν, δ)
δF (t1−α(ν); ν, δ)
∣∣∣∣∣
δ=
√
x
= −1
2
(
1 + o(1))
as ν, x→∞. So, for 0 ≤ yn ≤ xn →∞ with yn/xn → 0, we have
H(x2n)−H(x2n − y2n) = y2nH(zn) = −
y2n
2
(1 + o(1)) ,
where zn ∈ (x2n − y2n, x2n). Hence
F (t1−α(ν); ν, xn)
F
(
t1−α(ν); ν,
√
x2n − y2n
) = exp{−y2n
2
(1 + o(1))
}
. (6.2)
Now, let x2n =
µ2
4σ2ǫ
n, y2n =
µ2
4σ2ǫ
(
n− ℓ2n
)
. Then y2n =
µ2
2σ2ǫ
W 2n(1 + o(1)). It follows that
LossPT,n(µ|X) = exp
{
− u
2
8σ2ǫ
Wn
(
1 + o(1)
)}
(6.3)
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Finally, note Xn → 0 a.s. and
Sn,xx
n
=
1
n
{
n∑
i=1
(Xi −Xn)T (Xi −Xn)
−Nn,1
(
X
T
n,1Xn,1 −XTnXn
)−Nn,2(XTn,2Xn,2 −XTnXn)}
→Var(X) = diag(σ2x,1, · · · , σ2x,I) a.s.
We have
Wn =(Dn/
√
n)2 +
(
Dxn/
√
n
)T [
Var(X)
]−1(
Dxn/
√
n
)
+ o(1)
(
(Dn/
√
n)2 +
∥∥Dxn/√n∥∥2)
=Vn
(
1 + o(1)
)
.
(2.4) are proved. 
Proof of Theorem 2.2. Note that E[Xk|dk(Xk)] is a function of X˜k = dk(Xk). We
write it as fk(X˜k). Then Xi,k = δi,k + fk(X˜i,k). Under the conditions of
Dn(k;tk)√
n
→ 0,
tk = 1, . . . ,mk, k = 1, . . . , p, we have∑n
i=1(2Ti − 1)fk(X˜i,k)√
n
=
∑mk
tk=1
Dn(k; tk)fk(x˜
tk
k )√
n
→ 0.
Because the probability of Ti = 1 is a function of X˜1, . . . , X˜i, the sequence (2Ti−1)
(
δi,1, . . . , δi,I
)
,
i = 1, 2, . . . , is a sequence of martingale vector differences with
Var
(
(2Ti − 1)
(
δi,1, . . . , δi,I
)∣∣Fi−1) = diag (σ2δ,1, . . . , σ2δ,I) ,
where Fi is the history σ-field generated by T1, . . . , Ti−1, X˜1, . . . , X˜i−1. By the central limit
theorem of martingales, we have∑n
i=1(2Ti − 1)
(
δi,1, . . . , δi,I
)T
√
n
d→ NI
(
0, diag
(
σ2δ,1, . . . , σ
2
δ,I
))
.
Hence
Vn
d→
I∑
k=1
σ2δ,k
σ2x,k
χ2k(1).
The results follow. 
Proof of Remark 2.1. We first consider the two-sided t-test. Note that the distribution
function of T 2 is a F-distribution function F (t;m, ν, δ) with degree of freedom m = 1 and
ν = n− p− 2, and the non-central parameter δ = µ2
4σ2ǫ
ℓ2n, it is sufficient to show that
d
dδF (t;m, ν, δ)
F (t;m, ν, δ)
= −1
2
(
1 + o(1)
)
(6.4)
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uniformly in t ∈ [0, t0] as ν → ∞ and δ → ∞. The non-central F-distribution has the
following expansion
F (t;m, ν, δ) =
∞∑
j=0
e−δ/2
(δ/2)j
j!
F
(
m
m+ 2j
t;m+ 2j, ν, 0
)
=
∞∑
j=0
e−δ/2
(δ/2)j
j!
∫ t
0
f(x;m, ν, j)dx,
where
f(x;m, ν, j) =
Γ
(
(m+ ν)/2 + j
)
Γ(m/2 + j)Γ(ν)
νν/2mm/2+jxm/2−1+j
(ν +mx)(ν+m)/2+j
.
So,
dF (t;m, ν, δ)
dδ
+
1
2
F (t;m, ν, δ)
=
1
2
∞∑
j=0
e−δ/2
(δ/2)j
j!
∫ t
0
f(x;m, ν, j + 1)dx
=
1
2
∞∑
j=0
e−δ/2
(δ/2)j
j!
F
(
m
m+ 2(j + 1)
t;m+ 2(j + 1), ν, 0
)
.
It is obvious that
e−δ/2
(δ/2)j
j!
F
(
m
m+ 2(j + 1)
t;m+ 2(j + 1), ν, 0
)
=
2(j + 1)
δ
e−δ/2
(δ/2)j+1
(j + 1)!
F
(
m
m+ 2(j + 1)
t;m+ 2(j + 1), ν, 0
)
≤2(j + 1)
δ
F (t;m, ν, δ)
and ∫ t
0
f(x;m, ν, j + 1)dx ≤ ν +m+ 2j
m+ 2j
mt
ν +mt
∫ t
0
f(x;m, ν, j)dx.
It follows that
0 ≤dF (t;m, ν, δ)
dδ
+
1
2
F (t;m, ν, δ)
≤1
2
Km∑
j=0
2(j + 1)
δ
F (t;m, ν, δ)
+
1
2
∞∑
j=Km
e−δ/2
(δ/2)j
j!
(
mt
ν
+
mt
m+ 2j
)∫ t
0
f(x;m, ν, j)dx
≤
(
2(Km+ 1)2
δ
+
mt
ν
+
t
2K + 1
)
F (t;m, ν, δ).
(6.4) is proved.
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For the one-side z-test for (2.2), the test statistic is
U =
Lβˆ
(σ2ǫL(X
TX)−1LT )1/2
. (6.5)
The power function is
βU,n(µ|X) = 1− Φ(z1−α −
√
δ) with δ =
u2
4σ2ǫ
ℓ2n.
It is obvious that
d
dδΦ(z1−α −
√
δ)
Φ(z1−α −
√
δ)
→ −1
2
as δ →∞.
We have a similar result as (6.4).
For the two-side z-test for (2.10), the test statistic is U and the power function is
β|U |,n(µ|X) = 1− Φ(z1−α/2 −
√
δ) + Φ(−z1−α/2 −
√
δ) with δ =
u2
4σ2ǫ
ℓ2n.
It is easily seen that
d
dδΦ(z1−α/2 −
√
δ)− Φ(−z1−α/2 −
√
δ)
Φ(z1−α/2 −
√
δ)− Φ(−z1−α/2 −
√
δ)
=− 1
2
√
δ
ϕ(z1−α/2 −
√
δ)− ϕ(−z1−α/2 −
√
δ)
Φ(z1−α/2 −
√
δ)− Φ(−z1−α/2 −
√
δ)
∼− 1
2
√
δ
ϕ(z1−α/2 −
√
δ)
Φ(z1−α/2 −
√
δ)
→ −1
2
as δ →∞.
We have a similar result as (6.4). The proof is completed. 
6.2 Proofs of the results in Section 4
We now prove the results on covariate adaptive randomization procedures.
Recall that t = (t1, . . . , tI), ti = 1, . . . ,mi, i = 1, . . . , I, has M =
∏I
k=1mk values. Our
purpose is to the study the properties of Dn = [Dn(t)]. Besides Dn, we will also consider
the weighted average of the imbalances Λn−1(t) as in (2.1). Let
Λn(t) =woDn +
I∑
i=1
wm,iDn(i; ti) + wsDn(t),
Λn = [Λn(t)]1≤t1≤m1,...,1≤tI≤mI .
Also let Fn−1 be the history σ-field generated by the covariates X˜1, . . . , X˜n−1 and results
of allocation T1, . . . , Tn−1. Then the allocation probability in (4.1) of the nth patient as
P
(
Tn = 1
∣∣Fn−1, X˜n = (x˜t11 , . . . , x˜tII )) = gn (4Λn−1(t)) .
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is a function of Λn−1. It is obvious that Λn = L(Dn) : Dn → Λn is a linear transform of
Dn. The following proposition gives the relation between Dn and Λn and tells us that both
(Dn)n≥1 and (Λn)n≥1 are Markov chains.
Proposition 6.1 (i) If ws > 0, then Λn = L(Dn) is a one to one linear map; If ws+wm,i >
0, then each Dn(i; ti) = Di;ti(Λn) is a linear transform of Λn; For any case, Dn = D(Λn)
is a linear transform of Λn.
(ii) (Dn)n≥1 is a non-homogeneous Markov chain on the space Zm with period 2;
(iii) (Λn)n≥1 is a non-homogeneous Markov chain on the space L(Zm) with period 2.
Proof. For (i), taking the summation of Λn(t) over all t yields
∑
t
Λn(t) =
(
ws +
I∑
i=1
wm,i
∏
j 6=i
mj + woM
)
Dn.
So Dn is a linear transform of Λn. Taking the summation of Λn(t) over all t1, . . . , tI except
ti yields ∑
t1,...,ti−1,ti+1,...,tI
Λn(t1, . . . , tI)
=
(
ws + wm,i
∏
j 6=i
mj)Dn(i; ti) +
(∑
l 6=i
wm,l
∏
j 6=i,l
mj + wo
∏
j 6=i
mj
)
Dn.
Hence, when ws + wm,i > 0, each Dn(i; ti) is a linear transform of Λn and Dn, and so it
is a linear transform of Λn. Finally, when ws > 0, it is obvious that each Dn(t) is a linear
transform of Λn(t), Dn(1; t1), . . . ,Dn(I; tI) and Dn, and so it is a linear transform of Λn.
Hence, when ws > 0, Λn = L(Dn) is a one to one linear map.
For (ii) and (iii), notice
Dn(t) = Dn−1(t) + 2
(
Tn − 1
2
)
I{X˜n = (x˜t11 , . . . , x˜tII )}.
Then
P(∆Dn(t) = 1|Fn−1) =gn(4Λn−1(t))p(t),
P(∆Dn(t) = −1|Fn−1) =
[
1− gn
(
4Λn−1(t)
)]
p(t),
P(∆Dn(t) = 0|Fn−1) =1− p(t).
Let ∆D be the state space of ∆Dn = Dn −Dn−1, i.e., each d ∈ ∆D has only one non-
zero element which is 1 or −1. For two vectors x and y on Zm1×...×mI , we write x · y =
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∑
t
x(t)y(t), |x| = (|x(t)|). The conditional probability above can be write in the following
form,
P(∆Dn = d|Fn−1) =
(
gn(4|d| ·Λn−1)− 1
2
)
d · p+ 1
2
|d · p| (6.6)
=
(
gn (4|d| · L(Dn−1))− 1
2
)
d · p+ 1
2
|d · p|,
d ∈ ∆D ,
which depends only on Λn−1 = L(Dn−1). So, conditional on Dn−1, Dn is conditionally
independent of (D1, . . . ,Dn−2). It follows that (Dn)n≥1 is a Markov chain on Zm.
For (iii), note for any point e in the state space {L(d) : d ∈ ∆D} of ∆Λn,
P(∆Λn = e|Fn−1) =∑
d:L(d)=e,d∈∆D
{(
gn(4|d| ·Λn−1)− 1
2
)
d · p+ 1
2
|d · p|
}
, (6.7)
which depends only onΛn−1. So, givenΛn−1, Λn is conditionally independent of (Λ1, . . . ,Λn−2).
It follows that Λn is a Markov chain. The proof of Proposition 6.1 is completed. 
Proof of Theorem 4.1. Recall
Mn =
∑
t
wsD
2
n(t) +
I∑
i=1
mi∑
ti=1
wm,iD
2
n(i; ti) +woD
2
n.
By Proposition 6.1 (i), Mn =M
∗(Λn) is a function of Λn, and Mn ≤ C‖Λn‖2. On the other
hand,
|Λn(t)|2 ≤
(
wo|Dn|+
I∑
i=1
wm,i|Dn(i; ti)|+ ws|Dn(t)|
)2
≤ (wo|Dn|2 + I∑
i=1
wm,i|Dn(i; ti)|2 + ws|Dn(t)|2
)
(wo +
I∑
i=1
wm,i + ws),
= wo|Dn|2 +
I∑
i=1
wm,i|Dn(i; ti)|2 + ws|Dn(t)|2,
which implies that ‖Λn‖2 ≤ M ·Mn. We will prove the theorem via two steps. First, we
will show that under condition (4.5),
Mn = O(n) in Lr ∀r > 0. (6.8)
In the second step, we will show that under conditions (4.5) and (4.6),
Mn = o(n) in probability, (6.9)
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which, together with (6.8), implies that Mn = o(n) in Lr for any r > 0. (i)-(iii) follows from
immediately. Finally,
E [pn ∨ (1− pn)] =1
2
+
∑
t
p(t)E
∣∣∣1
2
− gn
(
4Λn−1(t)
)∣∣∣→ 1
2
due to the condition (4.7) and the fact that ‖Λn‖n ≤ CM
1/2
n
n → 0 in probability. Hence
SBn =
1
n
n∑
m=1
E [pm ∨ (1− pm)]→ 1
2
.
Now, we begin the proofs of (6.8) and (6.9). Given X˜n = (x˜
t1
1 , . . . , x˜
tI
I ), if Tn = 1, then
Mn −Mn−1 =ws
{(
Dn−1(t) + 1
)2 −D2n−1(t)}
+
I∑
i=1
wm,i
{(
Dn−1(i; ti) + 1
)2 −D2n−1(i; ti)}
+ wo
{
(Dn−1 + 1)2 −D2n−1
}
=2Λn−1(t) + 1,
while, if Tn = 0, then Mn −Mn−1 = −2Λn−1(t) + 1. So,
Mn −Mn−1 = 2Λn−1(t) (2Tn − 1) I{X˜n = (x˜t11 , . . . , x˜tII )}+ 1. (6.10)
Hence
E
[
Mn −Mn−1
∣∣X˜n = (xt11 , . . . , xtII ),Fn−1]
=2Λn−1(t) [2gn(4Λn−1(t))− 1] + 1
=− 4
∣∣∣Λn−1(t)∣∣∣ · ∣∣∣∣12 − gn (4Λn−1(t))
∣∣∣∣+ 1,
due the condition that gn(−x) ≤ 1/2 ≤ gn(x) when x ≥ 0. It follows that
E
[
Mn
∣∣Fn−1]−Mn−1 = −4Sn(Λn−1) + 1, (6.11)
where
Sn(Λn−1) =
∑
t
∣∣∣Λn−1(t)∣∣∣ · ∣∣∣∣12 − gn (4Λn−1(t))
∣∣∣∣ p(t)
is a nonnegative function of Λn−1.
From (6.11) and by noting M0 = 0, it follows that
E [Mn] ≤ n. (6.12)
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Further, by (6.10) we have
Mn =Mn−1 + 1 + 2Λn−1(t)(2Tn − 1)I{X˜n = (x˜t11 , . . . , x˜tII )}
=̂Mn−1 + 1 + ξ.
It is obvious that
|ξ| = 2|Λn−1(t)| ≤ 2
√
Mn−1, E[ξ|Fn−1] = −4Sn(Λn−1).
It follows that for positive integer r,
M r+1n −M r+1n−1 = (r + 1)(Mn−1 + 1)rξ
+
{
(Mn−1 + 1)r+1 −M r+1n−1 +
r+1∑
k=2
(
r + 1
k
)
ξk(Mn−1 + 1)r+1−k
}
≤ (r + 1)(Mn−1 + 1)rξ + Cr(Mn−1 + 1)r,
where Cr is a constant which depends on r. It follows that
E[M r+1n |Fn−1]−M r+1n−1
≤− 4(r + 1)(Mn−1 + 1)rSn(Λn−1) + Cr(Mn−1 + 1)r (6.13)
≤Cr(Mn−1 + 1)r.
By (6.12) and the induction we conclude (6.8). Obviously, (6.8) implies
‖Λn‖
n
→ 0 in probability.
Next, we consider (6.9). By (6.11),
E [Mn]− E [Mn−1] = −4E [Sn(Λn−1)] + 1. (6.14)
Let m := mn ∈ {0, 1, . . . , n} be the last one for which 1− 4E [Sm+1(Λm)] ≥ 0. Then
E [Mn] ≤ E [Mm+1] ≤ E [Mm] + 1
and
4E [Sm+1(Λm)] ≤ 1.
If m = mn is bounded, the proof is completed. Assume m → ∞. Note the condition (4.6)
implies
Sm+1(Λm)
1
m
∑
t
|Λm(t)|2p(t)
→ +∞ as ‖Λm‖
m
→ 0.
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On the other hand,
Mm ≥
∑
t
|Λm(t)|2p(t) ≥ c0Mm.
So for any 0 < ǫ < 1, the is a δ > 0 such that
Sm+1(Λm)I
{‖Λm‖
m
≤ δ
}
≥ 1
ǫ
1
m
MmI
{‖Λm‖
m
≤ δ
}
.
So
E
[
MmI
{‖Λm‖
m
≤ δ
}]
≤ ǫmE
[
Sm+1(Λm)
]
≤ ǫm
4
.
By a way,
E
[
MmI
{‖Λm‖
m
> δ
}]
≤
{
E
[
M2m
]}1/2{
P
(‖Λm‖
m
> δ
)}1/2
≤cmP1/2
(‖Λm‖
m
> δ
)
.
It follows that
E [Mn] ≤ n
{ ǫ
4
+ cP1/2
(‖Λm‖
m
> δ
)}
+ 1.
By the fact P
( ‖Λm‖
m > δ
)
→ 0, we conclude that E[Mn]n → 0. (6.9) is proved. The proof of
Theorem 4.1 is completed. 
Proof of Theorem 4.2. Note by (6.13),
E[M r+1n ]− E[M r+1n−1] ≤− 4(r + 1)E [(Mn−1 + 1)rSn(Λn−1)] + CrE [(Mn−1 + 1)r] .
Let m := mn ∈ {0, 1, . . . , n} be the last one for which
− 4(r + 1)E [(Mm + 1)rSm+1(Λm)] + CrE [(Mm + 1)r] ≥ 0. (6.15)
Then
E[M r+1n ] ≤ E[M r+1m+1] ≤ E[M r+1m ] + CrE [(Mm + 1)r] . (6.16)
Note for δ > 0 small enough, on the event
{
Mm
mγ ≤ δ
}
,
Sm+1(Λm) ≥ −g
′(0)
2
1
mγ
∑
t
|Λm(t)|2p(t) ≥ c0 1
mγ
Mm,
and on the event
{
Mm
mγ > δ
}
,
Sm+1(Λm) ≥
(1
2
− g(cδ)) ∨ (1
2
− g(−cδ))∑
t
|Λm(t)|p(t) ≥ c0M1/2m .
Let E = I
{
Mm
mγ > δ
}
. Then by (6.15),
E[M r+1m E
c] ≤ CrmγE [(Mm + 1)r] ,
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and
E[M r+1/2m E] ≤ CrE [(Mm + 1)r] .
By the Ho¨lder inequality,
E[M r+1m E] =E
[
M
r+1/2
p
m M
r+1/2
q
+ 1
2
m E
]
≤
(
E
[
M r+1/2m E
])1/p(
E
[
M
r+ 1
2
+ 1
2
q
m E
])1/q
≤Cr (E [(Mm + 1)r])1/p
(
E
[
M
r+ 1
2
+ 1
2
q
m
])1/q
≤Cr (E [(Mm + 1)r])1/p
(
E
[
M2r+1+qm
])1/2q
,
where p, q > 1, 1/p + 1/q = 1. We will use the induction method to obtain the moment
estimates of E[M rn] by inducting both in n and r. We assume
E[M sn] ≤ Csnβs for all integers n, s ≥ 0, (6.17)
and
E[M rn] ≤ Crnαr for all n, (6.18)
where 0 < β/2 < α ≤ β ≤ 2.
Let q be an integer large enough such that
αr
p
+ β
2r + 1
2q
+
1
2
β = αr +
r(β − α) + β/2
q
+
1
2
β ≤ (r + 1)α.
Then
E[M r+1m ] ≤Crmγmαr + Cr (mαr)1/p
(
mβ(2r+1+q)
)1/2q
≤Cr
(
mγmαr +mα(r+1)
)
.
By (6.16),
E[M r+1n ] ≤ Cr
(
nγnαr + nα(r+1)
) ≤ Cr+1nα(r+1) for all n, (6.19)
whenever α ≥ γ.
Obviously, (6.17) holds for β = 2 since Mn ≤ n2, and (6.18) is true for r = 0. So,
by (6.19) and the induction, (6.18) holds for all integer r whenever α > 1, which implies
that (6.17) holds for any β with β ≥ γ and β > 1. Repeating the above procedure i times
concludes that (6.17) holds for any β with β ≥ γ and β > 1/2i−1. Stooping the procedure
when 1/2i−1 < γ, we conclude that
EM rn ≤ Crnγr for all integers n and r.
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(4.10) is proved. By (4.10), for any ǫ, δ > 0,
∑
n
P
(
Mn ≥ δnγ+ǫ
) ≤∑
n
EMQn
δQnQγnǫQ
≤ C ≤
∑
n
n−ǫQ <∞
when Q > 1/ǫ. By the Borel-Cantelli lemma, (4.11) is proved. And so, (i)-(iii) follows by
Proposition 6.1.
Finally, we consider the selection bias. Note∣∣∣∣12 − gm+1 (4Λm(t))
∣∣∣∣ = −4g′(0)
∣∣Λm(t)∣∣
mγ
+ 4θm(t)
∣∣Λm(t)∣∣
mγ
, (6.20)
where
θm(t) =
∣∣∣ 12 − g (4Λm(t)mγ )∣∣∣
4|Λm(t)|
mγ
+ 4g′(0)
is bounded and converges to 0 in probability due to the fact that 0 ≤ g(x) ≤ 1, g′(0) is finite
and |Λm(t)|mγ → 0 in probability. So, Eθm(t)2 = o(1) as m → ∞. By the Cauchy-Schwartz
inequality,
E
∣∣∣∣∣θm(t)
∣∣Λm(t)∣∣
mγ
∣∣∣∣∣ = o(1) ·
E ∣∣∣∣∣
∣∣Λm(t)∣∣
mγ
∣∣∣∣∣
2
1/2 .
It follows that
E [pm ∨ (1− pm)] = 1
2
+
∑
t
p(t)E
∣∣∣∣12 − gm (Λm−1(t))
∣∣∣∣
=
1
2
+
∑
t
p(t)E
[
−4g′(0) |Λm−1(t)|
(m− 1)γ
]
+
∑
t
p(t)o(1)
E ∣∣∣∣∣
∣∣Λm−1(t)∣∣
(m− 1)γ
∣∣∣∣∣
2
1/2
=
1
2
− 4g′(0)
∑
t
p(t)
E [|Λm−1(t)|]
(m− 1)γ + o
(
1
(m− 1)γ/2
)
, (6.21)
where, the last equality are due to the fact that ‖Λm‖ ≤ CM1/2m = O(mγ/2) in any Lr.
Hence
SBn =
1
n
n∑
m=1
E [pm ∨ (1− pm)]
=
1
2
− 4g′(0) 1
n
n∑
m=1
∑
t
p(t)
E [|Λm(t)|]
mγ
+ o
(
1
nγ/2
)
=:
1
2
+ ann
−γ/2 + o
(
n−γ/2
)
.
Next, we show an is bounded from zero and infinity. From (6.14), we conclude that
0 = lim
n→∞
E[Mn+1]
n
= −4 lim
n→∞
1
n
n∑
m=1
E[Sm+1(Λm)] + 1.
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By noting (6.20), similar to (6.21) we have
E[Sm+1(Λm)] =− g′(0)
∑
t
p(t)
E|Λm(t)|2
mγ
+ o(1)
∑
t
p(t)E
(
E|Λm(t)|2
mγ
)2
=− g′(0)
∑
t
p(t)
E|Λm(t)|2
mγ
+ o(1).
It follows that
lim
n→∞
1
n
n∑
m=1
∑
t
p(t)
E|Λm(t)|2
mγ
=
1
−16g′(0) .
Regarding the summation of the right hand above as E|Zn|2 of a random variable Zn = Λτ (κ)τγ/2 ,
where P(τ = m) = 1n , P(κ = t) = p(t), then
1
n
n∑
m=1
∑
t
p(t)
E|Λm(t)|
mγ/2
= E|Zn| ≤ (E|Zn|2)1/2 ∼ 1
4
√
−g′(0) .
Hence
ann
−γ/2 = −4g′(0) 1
n
n∑
m=1
mE|Zm| − (m− 1)E|Zm−1|
mγ/2
∼− 4g′(0) 1
n
[
nE|Zn|
nγ/2
+
n−1∑
m=1
mE|Zm|
(
1
mγ
− 1
(m+ 1)γ/2
)]
(6.22)
≤− 4g′(0) 1
n
[
n(E|Zn|2)1/2
nγ/2
+
n−1∑
m=1
m(E|Zm|2)1/2
(
1
mγ
− 1
(m+ 1)γ/2
)]
∼
√
|g′(0)|
[
n−γ/2 +
1
n
n−1∑
m=1
m
(
1
mγ
− 1
(m+ 1)γ/2
)]
∼ 2
√|g′(0)|
2− γ n
−γ/2.
Hence lim sup
n→∞
an ≤ 2
√
|g′(0)|/(2 − γ).
On the other hand,
E|Zn|3 = 1
n
n∑
m=1
∑
t
p(t)
E|Λm(t)|3
m3γ/2
= O(1)
and EZ2n ≤ (E|Zn|)1/2(E|Zn|3)1/2. It follows that
lim inf
n→∞ an = lim infn→∞
[−4g′(0)] lim inf
n→∞ E|Zn|
≥ lim inf
n→∞
[−4g′(0)] (EZ2n
EZ3n
)2
≥ c0 > 0
by (6.22). (4.12) is proved. To show the constant c0 does not depend on γ. It is sufficient
to show that for any integer r ≥ 0, there is a constant Ar which does not depend on γ such
that
lim sup
n→∞
EM rn
nγr
≤ Ar. (6.23)
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We use the induction, assume (6.23) holds for r. We now consider r + 1. Let m = mn such
that (6.15) and (6.16) hold. Similar to (6.21), we have
cr
4(r + 1)
E(Mm + 1)
r ≥ E [(Mm + 1)rSm+1(Λm)]
=− 4g′(0)E
[
(Mm + 1)
r
∑
t
Λ2m(t)p(t)
mγ
]
+ o(1)
[
E
(
(Mm + 1)
r
∑
t
Λ2m(t)p(t)
mγ
)2]1/2
≥cm−γE [(Mm + 1)rMm] + o(1)m−γ
[
EM2(r+1)m
]1/2
=cm−γE
[
M r+1m
]
+ o(1)m−γmγ(r+1).
Hence, by (6.15),
E[M r+1n ] ≤ mγ
(
Cr
4(r + 1)c
+ Cr
)
E(Mm + 1)
r + o(1)mγ(r+1).
It follows that
lim sup
n→∞
E[M r+1n ]
nγ(r+1)
≤
(
Cr
4(r + 1)c
+ Cr
)
Ar,
by the induction. The proof is completed. 
Proof of the Remark 4.1. The proof can be found in Hu and Zhang (2013). For
the consistency of this paper, we give a skeleton of the proof here. The allocation function
probability g(4Λn−1(t)) is now only a function of Λn−1, so the Markov chain Λn is homo-
geneous. Note 0 < g(x) < 1 for all x. The transient probability in (6.7) is always positive.
So the Markov chain is irreducible. It can be verified that Sn(Λn−1)→ +∞ as Mn−1 →∞.
By (6.13), it follows that there is positive constants br and cr such that
E
[
M r+1n |Fn−1
]−M r+1n−1 ≤ −(Mn−1 + 1)r + brI {Mn−1 ≤ cr} .
Note Mn =M
∗(Λn) is a function of Λn. The above inequality just is
Pλ
(
M∗
)r+1 − (M∗)r+1 ≤ −(M∗ + 1)r + brI {M∗ ≤ cr} , (6.24)
where (Pλf)(Λ) =
∑
Λ′∈L(Zm) Pλ(Λ,Λ
′)f(Λ′) is the transient expectation of the function f ,
Pλ(Λ,Λ
′) is the transient probability from Λ to Λ′. Then (6.24) implies that the irreducible
Markov chain Λn with period 2 is positive recurrent with a invariant distribution π and
supn E
[
(Mn + 1)
r
]
<∞. In fact, write
P
(n)
λ (Λ,Λ
′) =
1
n
n−1∑
m=0
P
(m)
λ (Λ,Λ
′),
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where P
(m)
λ (Λ,Λ
′) is the m-step transient probability from Λ to Λ′. (6.24) implies that for
any initial distribution π0,
lim sup
n→∞
π0P
(n)
λ
(
M∗ + 1
)r ≤br lim sup
n→∞
π0P
(n)
λ I
{
M∗ ≤ C}+ lim sup
n→∞
π0
(
M∗
)r+1
n
≤br lim sup
n→∞
π0P
(n)
λ I
{
M∗ ≤ C}, ∀r > 0. (6.25)
If the Markov-Chain is not positive recurrent, then for any Λ and Λ′, P (n)λ (Λ,Λ′)→ 0. So,
for any C > 0, π0P
(n)
λ I {M∗ ≤ C} → 0. It follows that the limit in (6.25) is zero, which
is obvious a contradict. Hence Λn is a positive recurrent Markov Chain with an invariant
distribution π. Now, (6.25) implies
Eπ
[(
M∗ + 1
)r]
= πP
(n)
λ
(
M∗ + 1
)r ≤ br, ∀r > 0,
which implies En[M
r
n] < ∞ since 12
(
E[M r2n] + E[M
r
2n+1]
)
→ EπE[(M∗)r]. The proof is
completed. .
REFERENCES
[1] Aickin, M. (2009). A Simulation study of the validity and efficiency of design-adaptive allocation to
two groups in the regression situation. The International Journal of Biostatistics 5, 14.
[2] Baldi Antognini, A. (2008). A theoretical analysis of the power of biased coin designs. Journal of
Statistical Planning and Inference 138, 1792-1798.
[3] Atkinson, A. C. (1982). Optimum biased coin designs for sequential clinical trials with prognostic
factors. Biometrika 69, 61-67.
[4] Baldi Antognini, A. and Giovagnoli, A. (2004). A new ‘biased coin design’ for the sequential allocation
of two treatments. Journal of the Royal Statistical Society. Series C (Applied Statistics) 53, 651-664.
[5] Begg, C. B. and Iglewicz, B. (1980). A treatment allocation procedure for sequential clinical trials.
Biometrics 36, 81-90.
[6] Birkett, N. J. (1985). Adaptive allocation in randomized controlled trials. Controlled Clinical Trials
6, 146-155.
[7] Ciolino, J., Zhao, W., Martin, R., & Palesch, Y (2011). Quantifying the cost in power of ignoring
continuous covariate imbalances in clinical trial randomization. Contemporary Clinical Trials 32,
250-259.
[8] Efron, B. (1971). Forcing a sequential experiment to be balanced. Biometrika 58, 403-417.
[9] Feinstein, A. R., and Landis, J. R. (1976). The role of prognostic stratification in preventing the bias
permitted by random allocation of treatment. Journal of Chronic Diseases 29 277-284.
[10] Forsythe, A. B. (1987). Validity and power of tests when groups have been balanced for prognostic
factors. Computational Statistics and Data Analysis 5, 193-200.
36
[11] Green, S. B., and Byar, D. P. (1978). The effect of stratified randomization on size and power of
statistical tests in clinical trials. Journal of Chronic Diseases 31, 445-454.
[12] Hu, Y. and Hu, F. (2012). Asymptotic properties of covariate-adaptive randomization. Annals of
Statistics 40, 1794-1815.
[13] Hu, F. and Rosenberger, W. F. (2006). The Theory of Response-Adaptive Randomization in Clinical
Trials. John Wiley and Sons. Wiley Series in Probability and Statistics.
[14] Hu, F. and Zhang L.-X. (2004). Asymptotic properties of doubly adaptive biased coin designs for
multitreatment clinical trials. The Annals of Statistics 32, 268-301.
[15] Hu, F. and Zhang, L.-X. (2013). On the theory of covariate-adaptive designs. Manuscript.
[16] Hu, F., Zhang, L.-X. and He, X. (2009), Efficient randomized adaptive designs. The Annals of
Statistics 37, 2543-2560.
[17] Jing, B. Y., Shao, Q. M. and Wang, Q.Y. (2003). Self-normalized Crame´r-type large deviations for
independent random variables. Annals of Probability 31, 2167-2215.
[18] Ma, Hu, F. and Zhang, L.-X. (2015) Testing hypotheses of covariate-adaptive randomized clinical
trials. Journal of the American Statistical Association 110, 669-680
[19] McEntegart, D. J. (2003). The pursuit of balance using stratified and dynamic randomization tech-
niques: An overview. Drug Information Journal 37, 293-308.
[20] Meyn, S. P. and Tweedie, R. L. (1993). Markov chains and stochastic stability. Springer-Verlag,
London.
[21] Pocock, S. J. and Simon, R. (1975). Sequential treatment assignment with balancing for prognostic
factors in the controlled clinical trial. Biometrics 31, 103-115.
[22] Rosenberger, W. F. and Lachin, J. M. (2002). Randomization in Clinical Trials: Theory and Practice.
John Wiley and Sons. Wiley Series in Probability and Statistics.
[23] Rosenberger, W. F. and Sverdlov, O. (2008). Handling covariates in the design of clinical trials.
Statistical Science 23, 404-419.
[24] Scott, N. W., McPherson, G. C., Ramsay, C. R. and Campbell, M. K. (2002). The method of
minimization for allocation to clinical trials: A review. Control Clinical Trials 23, 662-674.
[25] Shao, J., Yu, X. and Zhong, B. (2010). A theory for testing hypotheses under covariate-adaptive
randomization. Biometrika 97, 347-360.
[26] Simon, R. (1979). Restricted aandomization designs in clinical trials. Biometrics 35 503-512.
[27] Smith, R. L. (1984). Properties of biased coin designs in sequential clinical trials. Annals of Statistics
12, 1018-1034.
[28] Taves, D. R. (1974). Minimization: A new method of assigning patients to treatment and control
groups. Clinical Pharmacology and Therapeutics 15, 443-453.
[29] Taves, D. R. (2010). The use of minimization in clinical trials. Contemporary Clinical Trials 31,
180-184.
37
[30] Toorawa, R., Adena, M., Donovan, M., Jones, S. and Conlon, J. (2009). Use of simulation to compare
the performance of minimization with stratified blocked randomization. Pharmaceutical Statistics 8,
264-278.
[31] Tu, D., Shalay, K. and Pater, J. (2000) Adjustment of treatment effect for covariates in clinical trials:
statistical and regulatory issues. Drug Information Journal 31, 180-184.
[32] Tymofyeyev, Y., Rosenberger, W.F. and Hu, F. (2007). Implementing optimal allocation in sequential
binary response experiments. Journal of the American Statistical Association 102, 224-234.
[33] Wei, L. J. (1978). The adaptive biased coin design for sequential experiments. Annals of Statistics,
6, 92- 100
[34] Zelen, M. (1974). The randomization and stratification of patients to clinical trials. Journal of Chronic
Diseases 27, 365-375.
[35] Zhang, L.X., Hu, F., Cheung. S.H. and Chan, W.S. (2007). Asymptotic properties of covariate-
adjusted adaptive designs. Annals of Statistics 35, 1166-1182.
[36] Zelen, M. (1974). The randomization and stratification of patients to clinical trials. Journal of Chronic
Diseases 27, 365C375.
38
